Clin2
NCT07463430Possibly a fitEnrolling by invitation

Suzetrigine for pain after non-mastectomy breast surgery

Pain, Acute PostoperativeBreast Disease

Treatments studied

Part of Pain, Skin clinical trials.

This trial tests a new pain medication, suzetrigine, for people having breast surgery (not mastectomy) who are expected to have moderate pain. It checks if this drug works well compared to standard options.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You are having surgery on one or both breasts that is likely to cause moderate pain (score of 4+ on a 0–10 pain scale)
  • You are scheduled to get a single injection of a nerve block during surgery
  • You do not take opioids or tramadol daily (if you have, it must have been for less than 2 weeks and not for more than 4 weeks total)
  • You do not have a history of opioid misuse or dependence
  • You are not currently pregnant, and if you could become pregnant, you are willing to avoid sexual activity or use extra nonhormonal birth control for a month after surgery

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07672015Recruiting· Phase 4
Testing a new pain drug in surgery patients at risk for opioid dependence

This trial tests a new painkiller called suzetrigine for post-surgery pain. It's designed for people whose medical records suggest they may have a higher chance of needing strong painkillers (opioids) long after surgery. We want to see if suzetrigine works better at preventing that.

La Jolla, California
NCT07600697Not yet recruiting· Phase 4
Non-opioid pain medicine after vaginal pelvic surgery

This study tests a new non-opioid pain medicine called suzetrigine to see if it can control pain after vaginal pelvic surgery while reducing the need for opioid painkillers. If you are having this type of surgery soon, this trial might offer you an alternative for pain management.

Los Angeles, California
NCT07145346Enrolling by invitation· Phase 4
Suzetrigine for pain relief after multiple rib fractures

This trial tests a new medicine, suzetrigine, for managing acute pain in adults who have broken three or more ribs from a blunt injury. It aims to see if this painkiller works well and is safe for you.

Orange, California
NCT07539623Recruiting· Phase 3
Pain relief with suzetrigine after heart or weight-loss surgery

This study tests whether suzetrigine, a new pain medication, can reduce the need for opioids (strong painkillers) after cardiac or bariatric surgery. The goal is to help patients manage pain with fewer opioid-related side effects.

New York, New York
NCT07795827Not yet recruiting· Phase 4
Suzetrigine for pain after ankle replacement

This study tests a new non-opioid pain medicine called suzetrigine to see how well it controls pain after ankle replacement surgery. The goal is to manage pain with fewer opioid-related side effects.

NCT07654296Not yet recruiting· Phase 3
Suzetrigine for pain relief after ureteroscopy

This trial tests a new non-opioid pain medication called suzetrigine to see if it can help reduce pain after ureteroscopy, a procedure often used to treat kidney stones. If you're having this procedure, the study may help you manage pain with fewer side effects than opioids.

Boston, Massachusetts

Hear when a new Pain, Acute Postoperative trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.